Live Quote · NASDAQPHVSHealthcare· Biotechnology

Pharvaris N.V.

$31.28▼ 1.20%($-0.38)
MKT CAP $2.20BNEXT EARNINGS Apr 1, 2027
50%
Bullish
TickerSpark Score
42/100
▌ Weak
60
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHVS research report →

Analyst Price Target
$59.33+89.7% vs. today

Range $44 – $75

Analyst RatingBuy
14 Buy0 Hold0 Sell

Price Chart

+29.26% · this period
$38.86$31.27$23.68Nov 20May 26Nov 20
52-Week Range40% of range
Low
$23.15
Current
$31.28
High
$43.25